Quantcast

Latest Biosimilar Stories

2014-06-09 14:39:26

Health Affairs Reducing Maternal Mortality In Zambia and Uganda. Margaret E. Kruk of Columbia University and co-authors assessed the effectiveness of Saving Mothers, Giving Life, a new global public-private partnership that aims to reduce maternal mortality in eight districts in Uganda and Zambia. They evaluated the first six to twelve months of the program's implementation, its ownership by national ministries of health, and its effects on health systems. According to the authors, early...

2014-06-09 08:29:01

REDWOOD CITY, Calif., June 9, 2014 /PRNewswire/ -- Coherus BioSciences, Inc. ("Coherus"), is pleased to announce the appointment of Vince R. Anicetti as Senior Vice President, Global Quality. Mr. Anicetti joins Coherus with more than 30 years of experience in quality and regulatory affairs at preeminent biotech companies. "Vince's breadth and depth of experience will be critical to delivering to patients high-quality biosimilars with robust consistency," said Denny Lanfear,...

2014-06-04 08:33:48

WASHINGTON, June 4, 2014 /PRNewswire-USNewswire/ -- In a letter submitted today to the U.S. Food and Drug Administration (FDA), the National Organization for Rare Disorders (NORD) urged Commissioner Margaret Hamburg to give serious consideration to the concerns of the rare disease community when setting policy regarding official names for biologics, including biosimilars. With over 7,000 rare diseases identified and 30 million Americans affected, the patient population represented by NORD is...

2014-06-03 23:03:26

Regulating Biosimilars; Stem Cell Therapies and 3-D Printing; Increasing FDA Oversight Overseas Washington (PRWEB) June 03, 2014 Hot topics facing drug development and access—evolving regulatory guidelines for novel therapies, a shifting pharmaceutical research and development (R&D) landscape, and U.S. regulatory challenges at home and overseas—will be discussed by global innovators at the DIA 2014 50th Annual Meeting, to be held at the San Diego Convention Center from June 15 to...

2014-06-02 08:31:48

CRANBURY, N.J., June 2, 2014 /PRNewswire/ -- Ipca Laboratories Ltd., India (Ipca) and Oncobiologics, Inc., USA (Oncobiologics) announced today the creation of a two-part alliance for the development, manufacture and commercialization of biosimilar monoclonal antibody products. Under the first part of the agreement, Ipca will in-license and commercialize biosimilar products for the India and associated markets. These products will be developed by Oncobiologics to US FDA and EU...

2014-05-27 23:13:40

In an upcoming webinar from Atlantic Information Services, participants will learn how to manage specialty drug coupons without compromising patient access. Washington, DC (PRWEB) May 27, 2014 As the biologics pipeline continues to grow and patients face increasing specialty copays, co-insurance and maximum out-of-pocket limits, manufacturer-offered specialty drug coupons are becoming more commonplace. And with biosimilars soon entering the market, it will be critical for payers to...

2014-05-21 23:03:36

New research report “The Future of Biosimilars: mapping critical uncertainties and the impact of future events” by FirstWord is now available at MarketPublishers.com. London, UK (PRWEB) May 21, 2014 At present, the world biosimilars industry is on the verge of considerable progress and is deemed to have lucrative growth prospects. Certain policy changes are predicted to play an essential part in the development of the world biosimilars industry moving forward. A number of changes are...

2014-05-20 12:34:14

DUBLIN, May 20, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/9trl4k/11th_annual) has announced the addition of the "11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The 11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production from BioPlan Associates, Inc., a global analysis of 238 biomanufacturers and...

2014-05-19 16:24:15

NEUDORF SPECIAL ECONOMIC ZONE, ST. PETERSBURG, Russia, May 19, 2014 /PRNewswire/ -- Head of the Russian Government Dmitri Medvedev visited today CJSC BIOCAD's [http://www.biocad.ru/en/we ] commercial manufacturing facility for mAb-based therapeutic proteins. This private facility is unique in Russia and Easter Europe. It produces monoclonal antibodies-based APIs for biological products that are widely used in treating oncological and autoimmune disorders. The visit occurred in...

2014-05-19 08:29:14

PASADENA, Calif., May 19, 2014 /PRNewswire/ -- Meditope Biosciences, Inc., a biotechnology company developing novel antibody-drug conjugates (ADC) using its proprietary monoclonal antibody (mAb) technology platform, today announced the appointment of C. Dan Dumitru, M.D., Ph.D., as Vice President of Translational Research. "We are delighted to expand our highly focused team to include Dan, who brings a strong background in preclinical and translational drug development for biologics...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related